Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| March 10th, 2022 |
Innovations in Nutrition Programs and Services - Replication |
Administration for Community Living |
| December 11th, 2023 |
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) |
National Institutes of Health |
| December 11th, 2023 |
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 4th, 2022 |
FY2022 AmeriCorps State and National Tribal Grants |
AmeriCorps |
| January 5th, 2022 |
FY2022 AmeriCorps State and National Grants |
AmeriCorps |
| September 9th, 2024 |
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2021 |
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 19th, 2021 |
The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2024 |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) |
National Institutes of Health |
| September 7th, 2024 |
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2024 |
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2024 |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| July 12th, 2024 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 12th, 2024 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) |
National Institutes of Health |
| September 7th, 2024 |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
National Institutes of Health |
| October 19th, 2021 |
An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 10th, 2021 |
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required) |
National Institutes of Health |
| February 1st, 2022 |
Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA) |
Centers for Disease Control and Prevention ERA |
| February 28th, 2022 |
Technological Advancement of Global Rabies Surveillance and Control |
Centers for Disease Control and Prevention ERA |
| November 8th, 2021 |
FY2022 AmeriCorps State and National Public Health AmeriCorps |
AmeriCorps |
|
| December 11th, 2023 |
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| December 11th, 2023 |
Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
National Institutes of Health |
| February 9th, 2022 |
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional) |
National Institutes of Health |
| October 11th, 2024 |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 4th, 2022 |
Research Grants for Preventing Violence and Violence Related Injury (R01) |
Centers for Disease Control and Prevention ERA |
| February 4th, 2022 |
Research Grants to Prevent Firearm-Related Violence and Injuries (R01) |
Centers for Disease Control and Prevention ERA |
| January 12th, 2022 |
Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors |
Centers for Disease Control and Prevention ERA |
| February 15th, 2024 |
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| February 9th, 2022 |
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional) |
National Institutes of Health |
| June 8th, 2023 |
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
| May 2nd, 2022 |
I-FASD: Understanding Clinical Data and Pathways to Inform Surveillance of Children with Fetal Alcohol Spectrum Disorders |
Centers for Disease Control NCBDDD |
| September 7th, 2024 |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2024 |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 8th, 2024 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
National Institutes of Health |
| December 21st, 2021 |
NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2024 |
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 15th, 2021 |
Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional) |
National Institutes of Health |
| December 21st, 2021 |
Limited Competition for the Data Coordinating Center (DCC) for the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U24 Clinical Trial Optional) |
National Institutes of Health |
| July 12th, 2024 |
NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2024 |
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
